Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
The number one priority with cell and gene therapies during transportation is maintaining the integrity of the drug, as well as ensuring it arrives on time to its destination and within temperature specification.
The task of maintaining speed, temperature, and integrity becomes much more complicated with these drugs. In addition to strict temperature and timing requirements, cell and gene therapy supply chains are more complicated than traditional life science supply chains.
Download this brochure to learn the key considerations for evaluating transportation partners.